BRIM Biotechnology, Inc. (TPEX: 6885)
48.95
+0.35 (0.72%)
Sep 11, 2024, 2:59 PM CST
BRIM Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 1,008 | 948 | 837.99 | 399.75 | 83.03 | 346.9 |
Short-Term Investments | 552.35 | 747.63 | - | 23.84 | 86.42 | 86.42 |
Cash & Short-Term Investments | 1,561 | 1,696 | 837.99 | 423.59 | 169.45 | 433.32 |
Cash Growth | 125.76% | 102.34% | 97.83% | 149.98% | -60.90% | - |
Other Receivables | 9.85 | 6.24 | 0.45 | 0.37 | 0.63 | 3.2 |
Receivables | 9.85 | 6.24 | 0.45 | 0.37 | 0.63 | 3.2 |
Prepaid Expenses | 11.69 | 11.1 | 10.55 | 6.65 | 6.16 | 5.44 |
Total Current Assets | 1,582 | 1,713 | 848.99 | 430.61 | 176.24 | 441.96 |
Property, Plant & Equipment | 4.53 | 6.37 | 7.99 | 3.62 | 6.39 | 3.2 |
Long-Term Investments | 50.6 | 57.3 | 82.33 | 60.35 | 134.07 | - |
Other Intangible Assets | 1.94 | 1.34 | 0.09 | - | - | 0.06 |
Other Long-Term Assets | 0.79 | 0.7 | 0.59 | 0.86 | 0.59 | 0.56 |
Total Assets | 1,640 | 1,779 | 939.99 | 495.44 | 317.28 | 445.78 |
Accrued Expenses | 20.92 | 36.04 | 16.99 | 12.34 | 44.99 | 11.94 |
Current Portion of Leases | 1.53 | 3.48 | 3.63 | 2.85 | 3.58 | 2.68 |
Current Unearned Revenue | - | - | - | - | 1.12 | - |
Other Current Liabilities | 2.61 | 2.52 | 1.87 | 2.05 | 1.14 | 1.19 |
Total Current Liabilities | 25.06 | 42.05 | 22.48 | 17.23 | 50.82 | 15.8 |
Long-Term Leases | - | 0.11 | 2.81 | 0.32 | 2.64 | 0.15 |
Total Liabilities | 25.06 | 42.16 | 25.3 | 17.55 | 53.46 | 15.95 |
Common Stock | 1,158 | 1,158 | 932.54 | 692.54 | 588.86 | 587.84 |
Additional Paid-In Capital | 974.63 | 1,555 | 589.72 | 454.31 | 232.36 | 231.97 |
Retained Earnings | -701.26 | -1,149 | -771.19 | -746.92 | -641.47 | -553.53 |
Comprensive Income & Other | 184.22 | 173.56 | 163.63 | 77.96 | 84.07 | 80.69 |
Total Common Equity | 1,615 | 1,737 | 914.69 | 477.89 | 263.82 | 346.97 |
Minority Interest | - | - | - | - | - | 82.86 |
Shareholders' Equity | 1,615 | 1,737 | 914.69 | 477.89 | 263.82 | 429.83 |
Total Liabilities & Equity | 1,640 | 1,779 | 939.99 | 495.44 | 317.28 | 445.78 |
Total Debt | 1.53 | 3.59 | 6.44 | 3.16 | 6.22 | 2.83 |
Net Cash (Debt) | 1,559 | 1,692 | 831.55 | 420.42 | 163.23 | 430.5 |
Net Cash Growth | 127.43% | 103.48% | 97.79% | 157.57% | -62.08% | - |
Net Cash Per Share | 13.95 | 16.83 | 11.66 | 7.09 | 2.77 | 7.32 |
Filing Date Shares Outstanding | 115.75 | 115.75 | 93.25 | 59.65 | 58.89 | 58.78 |
Total Common Shares Outstanding | 115.75 | 115.75 | 93.25 | 59.65 | 58.89 | 58.78 |
Working Capital | 1,557 | 1,671 | 826.51 | 413.38 | 125.42 | 426.16 |
Book Value Per Share | 13.95 | 15.00 | 9.81 | 8.01 | 4.48 | 5.90 |
Tangible Book Value | 1,613 | 1,735 | 914.6 | 477.89 | 263.82 | 346.91 |
Tangible Book Value Per Share | 13.94 | 14.99 | 9.81 | 8.01 | 4.48 | 5.90 |
Machinery | 7.38 | 6.46 | 4.84 | 3.59 | 4.23 | 4.35 |
Leasehold Improvements | 3.44 | 3.44 | 3.19 | 3.07 | 3.07 | 3.07 |
Source: S&P Capital IQ. Standard template. Financial Sources.